- Home
- TRVG vs RCKT Comparison
TRVG vs RCKT Comparison
Compare TRVG & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- RCKT
- Stock Information
- Founded
- TRVG 2005
- RCKT 1999
- Country
- TRVG Germany
- RCKT United States
- Employees
- TRVG N/A
- RCKT N/A
- Industry
- TRVG EDP Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- TRVG Technology
- RCKT Health Care
- Exchange
- TRVG Nasdaq
- RCKT Nasdaq
- Market Cap
- TRVG 278.1M
- RCKT 328.6M
- IPO Year
- TRVG N/A
- RCKT N/A
- Fundamental
- Price
- TRVG $3.04
- RCKT $3.98
- Analyst Decision
- TRVG Buy
- RCKT Buy
- Analyst Count
- TRVG 4
- RCKT 13
- Target Price
- TRVG $4.38
- RCKT $12.88
- AVG Volume (30 Days)
- TRVG 28.0K
- RCKT 3.3M
- Earning Date
- TRVG 11-04-2025
- RCKT 11-06-2025
- Dividend Yield
- TRVG N/A
- RCKT N/A
- EPS Growth
- TRVG N/A
- RCKT N/A
- EPS
- TRVG N/A
- RCKT N/A
- Revenue
- TRVG $592,176,160.00
- RCKT N/A
- Revenue This Year
- TRVG $18.41
- RCKT N/A
- Revenue Next Year
- TRVG $11.57
- RCKT $3,592.75
- P/E Ratio
- TRVG N/A
- RCKT N/A
- Revenue Growth
- TRVG 7.39
- RCKT N/A
- 52 Week Low
- TRVG $1.60
- RCKT $2.19
- 52 Week High
- TRVG $5.83
- RCKT $18.87
- Technical
- Relative Strength Index (RSI)
- TRVG 34.05
- RCKT 60.21
- Support Level
- TRVG $3.12
- RCKT $3.63
- Resistance Level
- TRVG $3.27
- RCKT $4.07
- Average True Range (ATR)
- TRVG 0.07
- RCKT 0.28
- MACD
- TRVG -0.01
- RCKT 0.06
- Stochastic Oscillator
- TRVG 12.39
- RCKT 62.44
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.